CVS Health Corporation (CVS) is currently trading at $89.13. Based on 25 Wall Street analysts, the average target price is $116.28, implying a 30.5% upside. The consensus recommendation is STRONG BUY.
Over the past 30 days, the feed records 0 target raises and 1 target cut for CVS. Over the past 90 days, the feed records 9 target raises and 2 target cuts for CVS.
CVS Health Corporation
Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).
Price (USD)
Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price
| Firm | Date | PT action | Prior → Current |
|---|---|---|---|
| UBS | Sep 3, 2026 | Lowers | $126.00 → $118.00 |
| Argus Research | Aug 19, 2026 | Raises | $104.00 → $114.00 |
| JP Morgan | Aug 12, 2026 | Raises | $111.00 → $118.00 |
| UBS | Aug 6, 2026 | Raises | $122.00 → $126.00 |
| Evercore ISI Group | Aug 6, 2026 | Lowers | $130.00 → $125.00 |
| Barclays | Aug 6, 2026 | Raises | $106.00 → $108.00 |
| UBS | Jul 25, 2026 | Raises | $115.00 → $122.00 |
| Truist Securities | Jul 14, 2026 | Raises | $108.00 → $118.00 |
| Wells Fargo | Jul 13, 2026 | Raises | $103.00 → $123.00 |
| RBC Capital | Jul 9, 2026 | Raises | $107.00 → $113.00 |
| Cantor Fitzgerald | Jul 7, 2026 | Raises | $100.00 → $110.00 |
| B of A Securities | Jun 23, 2026 | Raises | $100.00 → $110.00 |
| Mizuho | Jun 8, 2026 | Raises | $110.00 → $115.00 |
| Morgan Stanley | Jun 4, 2026 | Raises | $106.00 → $111.00 |
| Truist Securities | Jun 1, 2026 | Raises | $102.00 → $108.00 |
| Barclays | May 26, 2026 | Raises | $101.00 → $106.00 |
| Mizuho | May 20, 2026 | Raises | $102.00 → $110.00 |
| Morgan Stanley | May 14, 2026 | Raises | $93.00 → $106.00 |
| Bernstein | May 13, 2026 | Raises | $94.00 → $106.00 |
| JP Morgan | May 12, 2026 | Raises | $101.00 → $111.00 |
PT action: Lowers
$126.00 → $118.00
PT action: Raises
$104.00 → $114.00
PT action: Raises
$111.00 → $118.00
PT action: Raises
$122.00 → $126.00
PT action: Lowers
$130.00 → $125.00
PT action: Raises
$106.00 → $108.00
PT action: Raises
$115.00 → $122.00
PT action: Raises
$108.00 → $118.00
PT action: Raises
$103.00 → $123.00
PT action: Raises
$107.00 → $113.00
PT action: Raises
$100.00 → $110.00
PT action: Raises
$100.00 → $110.00
PT action: Raises
$110.00 → $115.00
PT action: Raises
$106.00 → $111.00
PT action: Raises
$102.00 → $108.00
PT action: Raises
$101.00 → $106.00
PT action: Raises
$102.00 → $110.00
PT action: Raises
$93.00 → $106.00
PT action: Raises
$94.00 → $106.00
PT action: Raises
$101.00 → $111.00
Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.
$116.28
Based on 25 analysts
+30.46%
$113.99B
Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.
Major insider buying detected recently.
SANSONE GUY P (Director) - 1,570 shares
| Date | Name | Position | Transaction | Shares |
|---|---|---|---|---|
| 5/21/2026 | ROBBINS LARRY | Director | Sale at price 93.45 - 96.28 per share. | 3,372,000 |
| 5/8/2026 | MANDADI TILAK | Officer | Sale at price 89.58 per share. | 69,551 |
| 8/20/2025 | FINUCANE ANNE A | Director | Sale at price 71.02 per share. | 7,500 |
| 6/5/2025 | SANSONE GUY P | Director | Purchase at price 63.70 per share. | 1,570 |
| 5/6/2025 | ROBBINS LARRY | Director | Sale at price 66.67 - 69.66 per share. | 3,750,000 |
| 3/5/2025 | CLARK JAMES DAVID | Officer | Sale at price 66.35 per share. | 7,513 |
| 2/18/2025 | MAHONEY MICHAEL F | Director | Purchase at price 66.70 per share. | 30,000 |
| 1/23/2025 | NELSON STEVEN H | Officer | Purchase at price 53.70 per share. | 24 |
| 10/23/2024 | CAPOZZI HEIDI B | Officer | Purchase at price 56.47 - 62.24 per share. | 80 |
A. The current target price for CVS Health Corporation is $116.28, which implies a 30.5% upside from the current price of $89.13. This is based on the consensus of 25 Wall Street analysts.
A. Currently, there are 7 Strong Buy, 18 Buy, 2 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is STRONG BUY.
A. Over the past 6 months, there have been 4 insider buys and 5 insider sells. Insider selling is more prominent recently.
Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.
Read full disclaimer →